Related Experiment Videos
Variability in constraints and functional competence in adults with multiple sclerosis
Susan L Kasser1, Jeffrey A McCubbin, Karen Hooker
1University of Vermont, Burlington 05405, USA.
American Journal of Physical Medicine & Rehabilitation
|June 24, 2003
Summary
Multiple sclerosis (MS) patients show more stable daily function than fluctuating physical and psychological symptoms. Understanding symptom variability is key for managing MS and improving patient adjustment.
Area of Science:
- Neurology
- Rehabilitation Science
- Psychology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease characterized by physical and psychological impairments.
- Understanding the variability of these symptoms and their impact on daily functioning is crucial for effective management and intervention.
Purpose of the Study:
- To examine intraindividual changes in physical and psychological impairments in adults with MS.
- To assess the relationship between changes in specific deficits and functional competence in activities of daily living.
Main Methods:
- A multivariate, replicated, single-subject, repeated-measures design was employed.
- Five adults with MS were assessed over 4 months on leg strength, postural control, mood, fatigue, stress, self-efficacy, and functional competence.
- P-technique factor analyses were used to identify covarying variables over time.
Main Results:
- Covariation between physical and psychological variables was observed in four out of five participants.
- Stress and fatigue exhibited greater variability (32.3%-53.4% and 23.4%-5.9%, respectively) compared to physical impairments (<20%).
- Functional task performance demonstrated the least variability (0%-12.6%) compared to all impairments.
Conclusions:
- Greater stability in functional performance suggests effective coping mechanisms or symptom management strategies in MS.
- The significant variability in psychological symptoms highlights the challenges in psychological adjustment to MS.
- Findings offer insights for targeted clinical interventions and symptom management in multiple sclerosis.